Macrobian Biotech

About Macrobian Biotech

Macrobian Biotech was founded in May 2017 by Dr. Lars van der Heide and Prof. dr. Marten Smidt. With decades of collective experience in molecular neuroscience, the founders recognized the urgent need for innovative and effective treatments for Parkinson’s disease, a chronic disorder that affects millions of people worldwide. Their passion for advancing the field and improving patients’ quality of life inspired the creation of Macrobian Biotech. The company is currently housed at the Amsterdam Science Park, the heart of academic excellence in the Netherlands

Keywords

• Drug Development
• Molecular Neuroscience
• Parkinson'S Disease
• Target Identification

Address

• Headquarters

  Science Park 9041098 AmsterdamNoord-Holland, Netherlands